Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Diego de Miguel‐Pérez(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), María José Serrano(Instituto de Investigación Biosanitaria de Granada)
Cited by 118
Related Papers
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
|Breast Cancer Research|2019|182
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
|Critical Reviews in Oncology/Hematology|2020|135
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
|Annals of Oncology|2023|103
Cancer in a drop: Advances in liquid biopsy in 2024
|Critical Reviews in Oncology/Hematology|2025|31
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
|Critical Reviews in Oncology/Hematology|2024|22